We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $28.4 · 5 analysts
Stored first · Google News · Yahoo Finance (English)
ALTO Trades at a Discount Despite 344% Rally in a Year: What's Next?
MGP Ingredients to report Q2 2026 results on July 29 - scanx.trade
MGP Ingredients to report Q2 2026 results on July 29 scanx.trade
MGP Ingredients CEO to Discuss Q2 Results July 29 - Stock Titan
MGP Ingredients CEO to Discuss Q2 Results July 29 Stock Titan
MGP Ingredients to Report Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
FEDERATED HERMES, INC. Reduces Stake in MGP Ingredients Inc. - GuruFocus
FEDERATED HERMES, INC. Reduces Stake in MGP Ingredients Inc. GuruFocus
MGP Ingredients Inc (MGPI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MGP Ingredients Inc (MGPI) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $0.51 | — | — | $123.94M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.14 | — | — | $121.65M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $3.43 | — | — | $522.83M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $2.36 | — | — | $361.37M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 01. | TD Cowen | — | Maintain | Hold → Hold | — | TD Cowen: Hold |
| 2026. 02. 27. | Roth Capital | — | Maintain | Buy → Buy | — | Roth Capital: Buy |
| 2026. 02. 27. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 01. 22. | Benchmark | — | Initiate coverage | — → Buy | — | Benchmark: Buy |
| 2026. 01. 09. | TD Cowen | — | Maintain | Hold → Hold | — | TD Cowen: Hold |
| 2026. 01. 06. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.